Tiger Brokers

  • Quotes
  • Invest
  • Pricing
  • Download
  • Rewards
  • Help
  • TigerAI
  • Institution
    • Wealth and asset manager
    • Proprietary trading institutions
    • Introducing brokers
    • Third-party service provider
    • Esop
  • About
    • About us
    • Newsroom
    • Awards
  • LOGIN
  • SIGN UP
US StockDetailed Quotes
Provided by Tiger Trade Technology Pte. Ltd.

Vanda Pharmaceuticals

5.28
-0.1000-1.86%
Post-market: 5.26-0.0200-0.38%19:36 EDT
Volume:656.79K
Turnover:3.50M
Market Cap:319.24M
PE:-1.14
High:5.42
Open:5.42
Low:5.27
Close:5.38
52wk High:9.94
52wk Low:4.27
Shares:60.46M
Float Shares:51.04M
Volume Ratio:0.72
T/O Rate:1.29%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.6291
EPS(LYR):-3.7413
ROE:-77.81%
ROA:-22.38%
PB:1.45
PE(LYR):-1.41

Loading ...

OverviewCompanyNewsFilings

B. Riley Securities Reaffirms Their Buy Rating on Vanda (VNDA)

TIPRANKS
·
Feb 25

Vanda Pharmaceuticals price target raised to $17 from $14 at B. Riley

TIPRANKS
·
Feb 25

B. Riley Adjusts Vanda Pharmaceuticals Price Target to $17 From $14, Maintains Buy Rating

MT Newswires Live
·
Feb 25

Vanda Pharmaceuticals Announces FDA Acceptance Of Biologics License Application Filing For Imsidolimab For The Treatment Of Generalized Pustular Psoriasis

Reuters
·
Feb 25

FDA accepts Vanda’s imsidolimab BLA for generalized pustular psoriasis review

Reuters
·
Feb 25

Vanda Pharmaceuticals Inc - Target Action Date of December 12, 2026

THOMSON REUTERS
·
Feb 25

Vanda Pharmaceuticals Announces FDA Acceptance of Biologics License Application Filing for Imsidolimab for the Treatment of Generalized Pustular Psoriasis

THOMSON REUTERS
·
Feb 25

Vanda Pharmaceuticals Director Honore Tage Disposes of Common Shares

Reuters
·
Feb 25

Analyst Rate

Buy
Buy
75.00%
Hold
25.00%
Sell
0.00%

Corporate Actions

Financial Report Announcement
Aug 05, 2026 Post-Mkt
Financial Report Announcement
May 06, 2026 Post-Mkt
Financial Report Announcement
Feb 11, 2026 Post-Mkt
Financial Report Announcement
Oct 29, 2025 Post-Mkt
Financial Report Announcement
Jul 31, 2025 Pre-MKt

Dividend History

no data

No relevant data is available

Valuation Analysis

-1.14
Current
16.84
Sector Average
45.11%
Historical Percentile
P/E[TTM]
+1 STD
Average
-1 STD
Current
-1.14
Maximum
113.97
+1 STD
52.98
Minimum
-77.38
-1 STD
-19.29
Average
16.84

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10
     
     
     
     
Company Name:
Tiger Trade Technology Pte. Ltd.
Email Address:
dpo@itiger.com
User Agreement|Privacy Policy

Copyright © Tiger Trade Technology Pte. Ltd.

Product offerings in different jurisdictions may vary.

Information contained on this website is general in nature and does not take into account of your investment objectives, financial situation and specific needs. It should not be regarded as an offer to sell, asolicitation to buy, a recommendation or endorsement for any financial product, nor does it constitute an investment forecast, investment return commitments, investment suggestions or other practical operating opinions. Information contained on this website is for reference only and past performance should not be construed as future performance. Investment involves risks. Before you make an investment decision, you should carefully judge and screen whether the information contained on this website is appropriate for your needs, goals and circumstances.

We strive but cannot guarantee the accuracy, completeness, reliability and timeliness of all information on this website, and we are not responsible for any losses caused by the use of or reliance on relevant information.

The products and services offered on the website are subject to applicable laws, regulations and relevant agreements. Please carefully read and agree to the agreements before using our products and services.